Search Results for: SARS-CoV-2

Smokers less likely to get COVID infection; vegetarians, too: CSIR study reveals

The pan India survey was conducted by an eminent team of 140 doctors and research scientists to study the presence of antibodies against SARS-CoV-2, assessed 10,427 adult individuals working in more than 40 CSIR laboratories

Apr 25, 2021

Even high Vitamin D dose fails to help Covid patients recover: New finding

Scientists now report that a high dose of vitamin D administered on admission to hospital has failed to improve the condition of patients with moderate or severe Covid-19.

Apr 24, 2021

Flushing public toilets propels Covid virus 5 feet up in air [details]

Respiratory droplets are the most prominent source of transmission for Covid-19. However, flushing a toilet can generate large quantities of microbe-containing aerosols depending on the design, water pressure or flushing power of the toilet at public restrooms, an Indian-origin researchers-led study has warned.

Apr 22, 2021

COVID-19 vaccine FAQs: All your concerns about anti-viral jab answered by experts

From mild reactions to no side effects at all to adverse and severe complications, there are a lot many questions regarding Covid vaccines

Apr 22, 2021

Indian-origin scientist spots genes that fight Covid infection

Indian American scientist spots genes that fight Covid infection

A team of US scientists, led by an Indian-origin researcher, has identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes Covid-19.

Apr 20, 2021

Coronavirus doesn't infect brain, yet causes considerable damage; new study shows

According to the paper, which is the largest published report detailing COVID-19 brain autopsies involving over 40 patients, there were no signs of the virus in the brain cells of the afflicted.

Apr 17, 2021

How does Remdesivir work; functioning of COVID-19 drug explained

Remdesivir, a broad-spectrum antiviral drug, from Gilead Sciences, is witnessing a resurgence in demand in India following the second wave of the COVID-19 pandemic. Here, we trace the drug's journey in helping fight the SARS-CoV-2 coronavirus.

Apr 16, 2021

Coronavirus is airborne; study cites overwhelming evidence, issues warning [details]

A multi-research team from the UK, US and Canada warned that public health measures that fail to treat the virus as predominantly airborne leave people unprotected and allow the virus to spread.

Apr 16, 2021

Prior to Covaxin, Bharat Biotech focused on many indigenous vaccines

Hyderabad-based Bharat Biotech played an integral role in the development of India's many indigenous vaccines prior to Covaxin

Apr 15, 2021

Children With COVID-19 Less Infectious Than Adults With The Disease, Finds Study

A study led by the University of Manitoba, Canada, involving 130 adults and 175 children, found that children infected with SARS-CoV-2 coronavirus were less contagious than adults infected with it.

Apr 11, 2021

How second wave of Spanish Flu devastated the world; COVID-19 presents similar problems

Similar to how the second wave of COVID-19 is threatening several countries including India, the second wave of Spanish flu was also worse than the first.

Apr 10, 2021

One in three COVID-19 survivors suffer from neurological, psychological disorders [details]

According to the study published in The Lancet Psychiatry, anxiety and mood disorders were the most common conditions that COVID-19 survivors were diagnosed with within 6 months of infection.

Apr 7, 2021

Covaxin, the more-preferred vaccine among Indians now, says survey: Here's its arduous journey to acceptance

A survey by 'LocalCircles' has found that 33 percent of Indians prefer Covaxin, the vaccine for COVID-19, produced by Bharat Biotech

Apr 6, 2021

Karnataka imposes restrictions amid COVID surge

Vaccination Drive: Covid survivors rush to take the jab in India

World Health Organisation (WHO) says for survivors of Covid infection, the "protection may not be lifelong", hence, vaccination is important.

Apr 5, 2021

This COVID vaccine shows 100% efficacy in 12-15 year olds; authorised for EUA [details]

Pharmaceutical companies Pfizer and BioNTech on Wednesday announced that their Covid-19 vaccine -- BNT162b2 -- demonstrated 100 per cent efficacy in adolescents in its phase 3 trial conducted in the US.

Mar 31, 2021

Prev 21 22 23 24 25 26 27 28 29 30 Next